<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-14T12:13:17+08:00</updated>
  <subtitle>世事洞明皆学问，人情练达即文章</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>JP摩根现场：这10位制药巨头掌门人的豪言……</title>
    <updated>2021-01-14T08:05:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/5-oHJvAVUuqoygG9pJKkvA</id>
    <link href="https://mp.weixin.qq.com/s/5-oHJvAVUuqoygG9pJKkvA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>治疗阿尔茨海默病！非侵入性神经刺激器获FDA突破性医疗器械认定</title>
    <updated>2021-01-14T08:05:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/0a3h_gpIe2Hk7NOZBRGX9A</id>
    <link href="https://mp.weixin.qq.com/s/0a3h_gpIe2Hk7NOZBRGX9A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>领袖汇聚倒计时丨本周五，中国肿瘤医药营销趋势论坛隆重启幕</title>
    <updated>2021-01-14T08:05:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/DRKVuK_FCW9o2leHzlxY9g</id>
    <link href="https://mp.weixin.qq.com/s/DRKVuK_FCW9o2leHzlxY9g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>跃迁之路 | 成为乘风破浪的高阶临床研究管理者</title>
    <updated>2021-01-14T08:05:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/xapqVYgodREbj0HCya9WlA</id>
    <link href="https://mp.weixin.qq.com/s/xapqVYgodREbj0HCya9WlA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国内眼科药物市场新旧势力，谁主沉浮？</title>
    <updated>2021-01-13T07:48:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/WzX2CwfndBaosB3j7kghtQ</id>
    <link href="https://mp.weixin.qq.com/s/WzX2CwfndBaosB3j7kghtQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>常兴点评 | Nature里程碑：碱基编辑疗法获突破！治疗早衰症，小鼠寿命从7个月延长至1.5年</title>
    <updated>2021-01-13T07:48:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/BEnXtfLa2Fpr5MDfZ7tDQg</id>
    <link href="https://mp.weixin.qq.com/s/BEnXtfLa2Fpr5MDfZ7tDQg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>克服PD-1耐药！祐和医药CD40激动剂联合特瑞普利单抗I/II期研究显示积极抗肿瘤活性</title>
    <updated>2021-01-12T07:25:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/DQf6vO6avWy52eaGQpWwAg</id>
    <link href="https://mp.weixin.qq.com/s/DQf6vO6avWy52eaGQpWwAg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>22亿美元！百济神州与诺华达成替雷利珠单抗授权合作协议</title>
    <updated>2021-01-12T07:25:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/iZtE-OKhWrvga1bqj1G6HQ</id>
    <link href="https://mp.weixin.qq.com/s/iZtE-OKhWrvga1bqj1G6HQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>12月肺癌月报 | 重磅文献18篇，新开关键临床试验12项</title>
    <updated>2021-01-12T07:25:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/qK_QlI6d9RJd-PJXcmpU_w</id>
    <link href="https://mp.weixin.qq.com/s/qK_QlI6d9RJd-PJXcmpU_w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>会前通知丨BIO APAC多的是你不知道的事！</title>
    <updated>2021-01-12T07:25:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/gFOeg4T_aukqsmtW8P9ZCA</id>
    <link href="https://mp.weixin.qq.com/s/gFOeg4T_aukqsmtW8P9ZCA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>维昇药业宣布完成1.5亿美元B轮融资，加速大中华区创新内分泌疗法研发</title>
    <updated>2021-01-11T07:45:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/PGj52rppZI0J-hfd9zFAKQ</id>
    <link href="https://mp.weixin.qq.com/s/PGj52rppZI0J-hfd9zFAKQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亿腾景昂药业和Aadi Bioscience就ABI-009（西罗莫司白蛋白结合型纳米颗粒）达成大中华区独家授权合作</title>
    <updated>2021-01-11T07:45:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/LLyjH9HLdohUOxufRw6AUA</id>
    <link href="https://mp.weixin.qq.com/s/LLyjH9HLdohUOxufRw6AUA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>领袖汇聚倒计时丨中国肿瘤医药营销趋势论坛—医学分论坛</title>
    <updated>2021-01-11T07:45:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/VARvnnnzNpFucBDn2VENCA</id>
    <link href="https://mp.weixin.qq.com/s/VARvnnnzNpFucBDn2VENCA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>巡礼2021｜从战略到执行，打造BD王者</title>
    <updated>2021-01-11T07:45:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/pVkUJvO_k2uLTX_-zpBtbQ</id>
    <link href="https://mp.weixin.qq.com/s/pVkUJvO_k2uLTX_-zpBtbQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>再鼎医药1.75亿美元引进重症肌无力新药！加码布局自身免疫疾病业务</title>
    <updated>2021-01-10T12:57:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/kE7G6TaSRiKVtw8W0cqJ9Q</id>
    <link href="https://mp.weixin.qq.com/s/kE7G6TaSRiKVtw8W0cqJ9Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亘喜生物纳斯达克IPO上市</title>
    <updated>2021-01-10T12:57:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/NIRCRAUD7ZcNsZOQOnMZ5w</id>
    <link href="https://mp.weixin.qq.com/s/NIRCRAUD7ZcNsZOQOnMZ5w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>男女均有效！开拓药业普克鲁胺阻止新冠患者轻症向重症转化，效果显著</title>
    <updated>2021-01-10T12:57:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/GfcsVrVCM_-mOMmANa9eCA</id>
    <link href="https://mp.weixin.qq.com/s/GfcsVrVCM_-mOMmANa9eCA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>江湖你我——2020年国内CRO行业回顾</title>
    <updated>2021-01-09T10:29:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/EU7bDGdjlMEXC1b72iLSrg</id>
    <link href="https://mp.weixin.qq.com/s/EU7bDGdjlMEXC1b72iLSrg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【最新综述】胰腺癌免疫疗法的机遇与挑战</title>
    <updated>2021-01-08T07:54:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/J54NfmLWqdRIsFTK9UFRjA</id>
    <link href="https://mp.weixin.qq.com/s/J54NfmLWqdRIsFTK9UFRjA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>维昇药业TransCon C-型利钠肽II期中国临床试验申请获批</title>
    <updated>2021-01-08T07:54:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/oQIsHk6acYRm0YpPYoufsA</id>
    <link href="https://mp.weixin.qq.com/s/oQIsHk6acYRm0YpPYoufsA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>